InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Walker Karin L, Directeur Comptable. Insider active across 2 companies, notably Cyclacel Pharmaceuticals, Inc.. Cumulatively, 7 reports have been logged. The latest transaction was filed on 14 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
015,822 shares0
Common Stock
SEC:0001104659-22-071903:0·
€60,4564,519 shares@ €13.37820.012% mcap19.0% of flow
Ordinary Shares, par value $0.01 per share
SEC:0001567619-21-021197·
€60,4564,519 shares@ €13.37820.012% mcap9.5% of flow
Ordinary Shares, par value $0.01 per share
SEC:0001567619-21-021197:0·
€258,08620,000 shares@ €12.90430.050% mcap81.0% of flow
Ordinary Shares, par value $0.01 per share
SEC:0001567619-21-018621·
€258,08620,000 shares@ €12.90430.050% mcap40.5% of flow
Ordinary Shares, par value $0.01 per share
SEC:0001567619-21-018621:0·
02,374 shares0
Common Stock
SEC:0001104659-21-082598·
02,374 shares0
Common Stock
SEC:0001104659-21-082598:0·
7 of 7 declarations
About Walker Karin L
Walker Karin L is the Chief Accounting Officer of Cyclacel Pharmaceuticals, Inc. and PROTHENA CORP PUBLIC LTD CO. She oversees the accounting operations of these companies, ensuring compliance and accuracy of financial reporting. Her role is essential for maintaining the financial health of the organization. Karin brings valuable expertise in accounting and financial management.
